Nascent Biotech Inc. Quarterly Revenues in USD from Q2 2016 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Nascent Biotech Inc. annual/quarterly Revenues history and growth rate from Q2 2016 to Q4 2022.
  • Nascent Biotech Inc. Revenues for the quarter ending December 31, 2022 was $0.000, a 100% decline year-over-year.
  • Nascent Biotech Inc. annual Revenues for 2022 was $0.000, a 100% decline from 2021.
  • Nascent Biotech Inc. annual Revenues for 2021 was $1M, a 33.3% increase from 2020.
  • Nascent Biotech Inc. annual Revenues for 2020 was $750K.
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $0 -$1M -100% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-14
Q4 2021 $1M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2016 $2.4M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $600K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.